These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17379469

  • 1. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.
    Netzel TC, Jindani I, Hanson N, Turner BM, Smith L, Rand KH.
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):345-8. PubMed ID: 17379469
    [Abstract] [Full Text] [Related]

  • 2. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH.
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [Abstract] [Full Text] [Related]

  • 3. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY, Ng SY, Teo L, Koh Y, Teok CH.
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [Abstract] [Full Text] [Related]

  • 4. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL, Nielsen JB, Friis-Møller A, Fjeldsøe-Nielsen H, Schønning K.
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [Abstract] [Full Text] [Related]

  • 6. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S, Chanawong A, Lulitanond A, Sribenjalux P, Auncharoen A, Kaewkes W, Songsri J, Pienthaweechai K.
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [Abstract] [Full Text] [Related]

  • 7. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S, Altanlar N.
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
    Lee K, Hong SG, Park YJ, Lee HS, Song W, Jeong J, Yong D, Chong Y.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
    [Abstract] [Full Text] [Related]

  • 9. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
    Wang WP, Shao HF, Wang JN, Zhang XW, Shi LN.
    Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
    [Abstract] [Full Text] [Related]

  • 10. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
    Jeong SH, Song W, Park MJ, Kim JS, Kim HS, Bae IK, Lee KM.
    Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
    [Abstract] [Full Text] [Related]

  • 11. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H, Midilli K, Oğünç D, Ozen N, Ongüt G, Dağlar D, Mutlu D, Ozhak B, Colak D.
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [Abstract] [Full Text] [Related]

  • 12. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM.
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [Abstract] [Full Text] [Related]

  • 13. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
    Deshpande LM, Jones RN, Fritsche TR, Sader HS.
    Int J Antimicrob Agents; 2006 Dec; 28(6):578-81. PubMed ID: 17112706
    [Abstract] [Full Text] [Related]

  • 14. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, Walsh TR, Sundsfjord A, Lundblad EW.
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test.
    Shahid M, Malik A, Agrawal M, Singhal S.
    J Antimicrob Chemother; 2004 Sep; 54(3):684-7. PubMed ID: 15294886
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of class A and AmpC β-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan.
    Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, Cha SB, Yoo HS.
    Jpn J Infect Dis; 2011 Sep; 64(3):249-52. PubMed ID: 21617313
    [Abstract] [Full Text] [Related]

  • 17. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
    Odeh R, Kelkar S, Hujer AM, Bonomo RA, Schreckenberger PC, Quinn JP.
    Clin Infect Dis; 2002 Jul 15; 35(2):140-5. PubMed ID: 12087519
    [Abstract] [Full Text] [Related]

  • 18. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae.
    Livermore DM, Mushtaq S, Nguyen T, Warner M.
    Int J Antimicrob Agents; 2011 May 15; 37(5):405-9. PubMed ID: 21276715
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E, Lang M, Horstkotte MA, Laufs R, Mack D.
    J Antimicrob Chemother; 2004 Nov 15; 54(5):870-5. PubMed ID: 15471997
    [Abstract] [Full Text] [Related]

  • 20. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    Rodríguez I, Barownick W, Helmuth R, Mendoza MC, Rodicio MR, Schroeter A, Guerra B.
    J Antimicrob Chemother; 2009 Aug 15; 64(2):301-9. PubMed ID: 19474065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.